Story perspectives

Inventia Recalls 11,460 Bottles Over Dissolution Failure

6/23/2026

33 5

Summary

Story summary

Inventia Healthcare Limited voluntarily recalled 11,460 bottles of 25 mg Chlorthalidone tablets in the United States because the tablets failed dissolution specifications.
The recalled bottles carry lot numbers RISA24001 and RISB24002 and are labeled to expire in April 2027.
Rising Pharma Holdings of New Jersey distributed the product nationwide.
The FDA has not assigned a recall class and advises patients to consult their pharmacist or doctor before stopping the medication.

1 of 1

Story summary

Inventia Healthcare Limited voluntarily recalled 11,460 bottles of 25 mg Chlorthalidone tablets in the United States because the tablets failed dissolution specifications.
The recalled bottles carry lot numbers RISA24001 and RISB24002 and are labeled to expire in April 2027.
Rising Pharma Holdings of New Jersey distributed the product nationwide.
The FDA has not assigned a recall class and advises patients to consult their pharmacist or doctor before stopping the medication.